Admission hyperglycemia and serial infarct volume after t-PA therapy in patients with and without early recanalization

Journal of the Neurological Sciences

Volumn 307, Issue 1-2, 2011, Pages 55-59

  Kimura, Kazumi ^a   Sakamoto, Yuki ^a   Iguchi, Yasuyuki ^a   Shibazaki, Kensaku ^a   Aoki, Junya ^a   Sakai, Kenichiro ^a   Uemura, Junichi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Early recanalization; Hyperglycemia; MRA; Outcome; Tissue plasminogen activator (t PA)

Indexed keywords

ALTEPLASE; GLUCOSE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECANALIZATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BRAIN INFARCTION; COMORBIDITY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79959820278     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.05.017     Document Type: Article

References (31)

1. T.A. Baird, M.W. Parsons, T. Phanh, K.S. Butcher, P.M. Desmond, and B.M. Tress Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome Stroke 34 2003 2208 2214 (Pubitemid 37099838)
2. S.E. Capes, D. Hunt, K. Malmberg, P. Pathak, and H.C. Gerstein Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview Stroke 32 2001 2426 2432 (Pubitemid 32954818)
3. M.W. Parsons, P.A. Barber, P.M. Desmond, T.A. Baird, D.G. Darby, and G. Byrnes Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study Ann Neurol 52 2002 20 28 (Pubitemid 34693739)
4. L.S. Williams, J. Rotich, R. Qi, N. Fineberg, A. Espay, and A. Bruno Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke Neurology 59 2002 67 71 (Pubitemid 34742796)
5. R. Garg, A. Chaudhuri, F. Munschauer, and P. Dandona Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy Stroke 37 2006 267 273 (Pubitemid 43732090)
6. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group N Engl J Med 333 1995 1581 1587
7. A. Zangerle, S. Kiechl, M. Spiegel, M. Furtner, M. Knoflach, and P. Werner Recanalization after thrombolysis in stroke patients: predictors and prognostic implications Neurology 68 2007 39 44 (Pubitemid 46058549)
8. M. Rubiera, J. Alvarez-Sabin, M. Ribo, J. Montaner, E. Santamarina, and J.F. Arenillas Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke Stroke 36 2005 1452 1456 (Pubitemid 40967511)
9. C.A. Molina, A.V. Alexandrov, A.M. Demchuk, M. Saqqur, K. Uchino, and J. Alvarez-Sabin Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator Stroke 35 2004 151 156 (Pubitemid 38057610)
10. G.W. Albers, V.E. Bates, W.M. Clark, R. Bell, P. Verro, and S.A. Hamilton Intravenous tissue-type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study JAMA 283 2000 1145 1150 (Pubitemid 30126602)
11. K. Toyoda, M. Koga, M. Naganuma, Y. Shiokawa, J. Nakagawara, and E. Furui Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register Stroke 40 2009 3591 3595
12. N. Wahlgren, N. Ahmed, A. Davalos, G.A. Ford, M. Grond, and W. Hacke Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITA-MOST): an observational study Lancet 369 2007 275 282 (Pubitemid 46138121)
13. N. Ahmed, N. Wahlgren, M. Brainin, J. Castillo, G.A. Ford, and M. Kaste Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR) Stroke 40 2009 2442 2449
14. W. Hacke, M. Kaste, C. Fieschi, D. Toni, E. Lesaffre, and R. von Kummer Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECCASS) JAMA 274 1995 1017 1025
15. K. Kimura, Y. Iguchi, K. Shibazaki, Y. Terasawa, T. Inoue, and J. Uemura Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke Stroke 39 2008 2388 2391
16. I. Linfante, R.H. Llinas, M. Selim, C. Chaves, S. Kumar, and R.A. Parker Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator Stroke 33 2002 2066 2071 (Pubitemid 34840069)
17. M. Ribo, C. Molina, J. Montaner, M. Rubiera, R. Delgado-Mederos, and J.F. Arenillas Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients Stroke 36 2005 1705 1709 (Pubitemid 41098766)
18. N. Wahlgren, N. Ahmed, N. Eriksson, F. Aichner, E. Bluhmki, and A. Davalos Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST) Stroke 39 2008 3316 3322
19. T. Yamaguchi, E. Mori, K. Minematsu, J. Nakagawara, K. Hashi, and I. Saito Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan alteplase clinical trial (J-ACT) Stroke 37 2006 1810 1815 (Pubitemid 44297734)
20. D.A. De Silva, M. Ebinger, S. Christensen, M.W. Parsons, C. Levi, and K. Butcher Baseline diabetic status and admission blood glucose were poor prognostic factors in the epithet trial Cerebrovasc Dis 29 2010 14 21
21. M. Paciaroni, G. Agnelli, V. Caso, F. Corea, W. Ageno, and A. Alberti Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke Cerebrovasc Dis 28 2009 119 123
22. J. Alvarez-Sabin, C.A. Molina, J. Montaner, J.F. Arenillas, R. Huertas, and M. Ribo Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients Stroke 34 2003 1235 1241
23. M.A. Albanese, W.R. Clarke, H.P. Adams Jr., and R.F. Woolson Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the trial of org 10172 in acute stroke treatment (TOAST) Stroke 25 1994 1746 1751 (Pubitemid 24274965)
24. K. Kimura, Y. Iguchi, S. Yamashita, K. Shibazaki, K. Kobayashi, and T. Inoue Atrial fibrillation as an independent predictor for no early recanalization after iv-t-PA in acute ischemic stroke J Neurol Sci 267 2008 57 61 (Pubitemid 351248907)
25. A.M. Demchuk, R.A. Felburg, and A.V. Alexandrov Clinical recovery from acute ischemic stroke after early reperfusion of the brain with intravenous thrombolysis N Engl J Med 340 1999 894 895 (Pubitemid 29142641)
26. R.E. Anderson, W.K. Tan, H.S. Martin, and F.B. Meyer Effects of glucose and pao2 modulation on cortical intracellular acidosis, nadh redox state, and infarction in the ischemic penumbra Stroke 30 1999 160 170 (Pubitemid 29029458)
27. T. Els, J. Klisch, M. Orszagh, A. Hetzel, J. Schulte-Monting, and M. Schumacher Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size Cerebrovasc Dis 13 2002 89 94 (Pubitemid 34195677)
28. W. Hacke, M. Kaste, E. Bluhmki, M. Brozman, A. Davalos, and D. Guidetti Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
29. E. Bluhmki, A. Chamorro, A. Davalos, T. Machnig, C. Sauce, and N. Wahlgren Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial Lancet Neurol 8 2009 1095 1102
30. G. Furst, A. Saleh, F. Wenserski, J. Malms, M. Cohnen, and A. Aulich Reliability and validity of noninvasive imaging of internal carotid artery pseudo-occlusion Stroke 30 1999 1444 1449 (Pubitemid 29296075)
31. E. Mori, K. Minematsu, J. Nakagawara, T. Yamaguchi, M. Sasaki, and T. Hirano Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion: Japan alteplase clinical trail II (J-ACT II) Stroke 41 2010 461 465